236 related articles for article (PubMed ID: 8835050)
1. Metformin: an antihyperglycemic agent for treatment of type II diabetes.
Melchior WR; Jaber LA
Ann Pharmacother; 1996 Feb; 30(2):158-64. PubMed ID: 8835050
[TBL] [Abstract][Full Text] [Related]
2. Metformin in noninsulin-dependent diabetes mellitus.
Lee AJ
Pharmacotherapy; 1996; 16(3):327-51. PubMed ID: 8726592
[TBL] [Abstract][Full Text] [Related]
3. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
4. Metformin hydrochloride: an antihyperglycemic agent.
Klepser TB; Kelly MW
Am J Health Syst Pharm; 1997 Apr; 54(8):893-903. PubMed ID: 9114921
[TBL] [Abstract][Full Text] [Related]
5. Treatment of non-insulin-dependent diabetes mellitus with metformin.
Guthrie R
J Am Board Fam Pract; 1997; 10(3):213-21. PubMed ID: 9159660
[TBL] [Abstract][Full Text] [Related]
6. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
Wildasin EM; Skaar DJ; Kirchain WR; Hulse M
Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
Johnson MD; Campbell LK; Campbell RK
Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
[TBL] [Abstract][Full Text] [Related]
8. Metformin: a safe and effective treatment in the management of NIDDM.
Kilo C
Mo Med; 1997 Mar; 94(3):114-23. PubMed ID: 9071866
[TBL] [Abstract][Full Text] [Related]
9. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.
Setter SM; Iltz JL; Thams J; Campbell RK
Clin Ther; 2003 Dec; 25(12):2991-3026. PubMed ID: 14749143
[TBL] [Abstract][Full Text] [Related]
10. The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials.
Zhang F; Xiang H; Fan Y; Ganchuluun TA; Kong W; Ouyang Q; Sun J; Cao B; Jiang H; Nie S
Endocrine; 2013 Dec; 44(3):648-58. PubMed ID: 23657947
[TBL] [Abstract][Full Text] [Related]
11. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
12. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
Sobieraj DM; Freyer CW
Ann Pharmacother; 2010; 44(7-8):1334-7. PubMed ID: 20516361
[TBL] [Abstract][Full Text] [Related]
13. An overview of metformin in the treatment of type 2 diabetes mellitus.
Davidson MB; Peters AL
Am J Med; 1997 Jan; 102(1):99-110. PubMed ID: 9209206
[TBL] [Abstract][Full Text] [Related]
14. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
Ryan GJ; Jobe LJ; Martin R
Clin Ther; 2005 Oct; 27(10):1500-12. PubMed ID: 16330288
[TBL] [Abstract][Full Text] [Related]
15. Metformin: a new oral biguanide.
Campbell RK; White JR; Saulie BA
Clin Ther; 1996; 18(3):360-71; discussion 359. PubMed ID: 8829014
[TBL] [Abstract][Full Text] [Related]
16. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
17. Role of metformin for weight management in patients without type 2 diabetes.
Desilets AR; Dhakal-Karki S; Dunican KC
Ann Pharmacother; 2008 Jun; 42(6):817-26. PubMed ID: 18477733
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.
Prescrire Int; 2014 Nov; 23(154):269-72. PubMed ID: 25954799
[TBL] [Abstract][Full Text] [Related]
19. Acarbose: its role in the treatment of diabetes mellitus.
Campbell LK; White JR; Campbell RK
Ann Pharmacother; 1996 Nov; 30(11):1255-62. PubMed ID: 8913408
[TBL] [Abstract][Full Text] [Related]
20. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.
Singh-Franco D; Robles G; Gazze D
Clin Ther; 2007 Apr; 29(4):535-62. PubMed ID: 17617279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]